Skip to content

iRhythm Holdings, Inc. IRTC Free cash flow margin

Free cash flow margin at other companies

Baxter International logo
Baxter InternationalBAX
3%-2.4pp
Boston Scientific logo
Boston ScientificBSX
16.9%-0.3pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
14.3%+1.3pp
Medtronic logo
MedtronicMDT
14.9%-0.5pp
Abbott logo
AbbottABT
16.3%+0.6pp
Cytokinetics logo
CytokineticsCYTK
-518.8%-223pp

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.44B+16.0%
Enterprise value$3.27B+21.8%
P/S4.4×-0.4×

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.5×-0.5×
Current ratio5.2×-0.5×

Where this comes from

Calculated from iRhythm Holdings, Inc. ’s reported figures.

Based on trailing twelve months.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's free cash flow margin?
iRhythm Holdings, Inc. (IRTC) reported free cash flow margin of 2.4% in Q1 2026.
What is the long-term trend for iRhythm Holdings, Inc. 's free cash flow margin?
Over 2 years (2021 to 2025), iRhythm Holdings, Inc. 's free cash flow margin has grown at a -53.9% compound annual growth rate (CAGR), from -21.7% to 4.6%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.